Cargando…
Plasma membrane expression of ZNF185 is a prognostic factor in pancreatic ductal carcinoma
Pancreatic ductal carcinoma (PDC) is one of the major causes of cancer-associated mortality globally due to its high potential for distant metastasis. To understand hematogenous metastasis, the molecular expression profiles of weak metastatic PDC cell subline BxPC-3 and highly liver-metastatic cell...
Autores principales: | Furukawa, Daisuke, Chijiwa, Tsuyoshi, Matsuyama, Masahiro, Mukai, Masaya, Matsuo, Ei-Ichi, Nishimura, Osamu, Kawai, Kenji, Suemizu, Hiroshi, Nakagohri, Toshio, Ozawa, Soji, Shimada, Kazuaki, Hiraoka, Nobuyoshi, Nakamura, Masato |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587964/ https://www.ncbi.nlm.nih.gov/pubmed/28927124 http://dx.doi.org/10.3892/ol.2017.6633 |
Ejemplares similares
-
Significance of pulmonary resection in patients with metachronous pulmonary metastasis from pancreatic ductal adenocarcinoma: a retrospective cohort study
por: Mashiko, Taro, et al.
Publicado: (2021) -
Neoadjuvant and Adjuvant Treatments for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: The Current Status of Pancreatic Ductal Adenocarcinoma Treatment in Japan
por: Ei, Shigenori, et al.
Publicado: (2023) -
Clinicopathological significance of core 3 O-glycan synthetic enzyme, β1,3-N-acetylglucosaminyltransferase 6 in pancreatic ductal adenocarcinoma
por: Doi, Noriteru, et al.
Publicado: (2020) -
ZNF185 is a p53 target gene following DNA damage
por: Smirnov, Artem, et al.
Publicado: (2018) -
Reduction of intrapancreatic neural density in cancer tissue predicts poorer outcome in pancreatic ductal carcinoma
por: Iwasaki, Toshimitsu, et al.
Publicado: (2019)